Patterns of XXXX morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population.

@entity1 @entity301 @entity944 @entity951 @entity1188 @entity583
A population-based survey, using data from the Framingham study, assessed sex-specific patterns of @entity301 occurring over a 26-year period of time. Among subjects ages 35 to 84 years, @entity1 have about twice the total incidence of morbidity and mortality of @entity1 . The sex gap in morbidity tends to diminish during the later years of the age range, mainly because of a surge in growth of female morbidity after age 45 years, while by that age, the growth in the male rate begins to taper off. An approximate 10-year difference between the sexes persists in mortality rates throughout the life span. The relative health advantage that is possessed by @entity1 , however, is buffered by a case fatality rate from coronary attacks that exceeds the male rate (32% vs 27%). @entity301 manifestations differ between the sexes. @entity583 is more likely to be unrecognized in @entity1 than in @entity1 (34% vs 27%). @entity951 in @entity1 more frequently is uncomplicated (80%), whereas in @entity1 angina tends to evolve out of @entity1188 (66%). Also, @entity944 comprises a greater proportion of male deaths than female deaths (50% vs 39%). Because @entity1 maintain a lesser probability of the disease than do @entity1 at any level of the major cardiovascular risk factors, distinctions in their risk factor profiles do not explain completely the observed disease patterns.
